Oncolytics Biotech Inc. ( ONCY) - Key Metrics
ONCY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.08 | -$0.04 | -$0.04 |
| 2026Q1 | $0 | -$0.08 | -$0.06 | -$0.06 |
| 2025Q4 | $0 | -$0.08 | -$0.06 | -$0.06 |
| 2025Q3 | $0 | -$0.10 | -$0.05 | -$0.05 |
| 2025Q2 | $0 | -$0.05 | -$0.04 | -$0.04 |
ONCY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.97 |
| 2026Q1 | 0% | -2.68 |
| 2025Q4 | 0% | -21.57 |
| 2025Q3 | 0% | -3.48 |
| 2025Q2 | 0% | -3.88 |
ONCY
Price: $0.58
52 week price:
Earnings Per Share: -0.34 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 110000
Market Capitalization: 88.3 million